The AHA yesterday voiced support for the Competitive Health Insurance Reform Act (H.R. 1418/S. 350), legislation that would repeal the antitrust exemption available to commercial health insurers for anticompetitive conduct. “The AHA believes that the commercial health insurance industry should be governed by the same antitrust laws and policies that apply in other sectors of our economy, including hospitals and other health care providers,” AHA said in a letter to Sen. Steve Daines, R-Mont., and Rep. Peter DeFazio, D-Ore., the lead sponsors of the legislation. “Any exemptions should be narrow and carefully tailored to achieve a pro-competitive purpose. We have previously articulated our concerns to the Department of Justice’s Antitrust Division about the abuse of market power by large commercial insurers; this remains a concern as large commercial insurers continue attempts to consolidate to the detriment of consumers.”

Related News Articles

Headline
The Trump administration today announced steps drug manufacturers must take to lower prescription drug prices in the U.S. to "most favored nation" pricing, the…
Headline
The Department of Health and Human Services today issued a notice announcing a 340B Rebate Model Pilot Program as a voluntary mechanism for qualifying drug…
Headline
The AHA’s Next Generation Leaders Fellowship July 29 announced its 36 fellows for the class of 2026, who will each work with mentors to address a specific…
Headline
The American Society for Health Care Engineering July 28 announced the recipients of its annual member awards during the 2025 Health Care Facilities Innovation…
Chairperson's File
Public
The recently enacted One Big Beautiful Bill Act will bring big changes to health care. AHA President and CEO Rick Pollack joined me for a Leadership Dialogue…
Headline
AHA Chair-elect Marc Boom, M.D., president and CEO of Houston Methodist, and AHA Immediate-past Chair Joanne Conroy, M.D., president and CEO of Dartmouth…